Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
BNP Paribas Exane modifie ce lundi sa recommandation sur Ipsen.
Ipsen announces the appointment of Michelle C. Werner as the new Executive Vice President (EVP) and President of North America, effective March 23, 20…
Ipsen announces the voluntary and immediate withdrawal of Tazverik (tazemetostat) from all markets where it is sold, across all indications. This deci…
This Friday, Ipsen reached a new historical high at 162.20 euros, surpassing the previous peak achieved the day before. The pharmaceutical company's s…
Ipsen's stock reached an unprecedented peak this Thursday, February 26, surpassing the previous high of 160.80 euros recorded the day before. The phar…
On Wednesday, February 18, 2026, Ipsen's stock reached a new all-time high, hitting €156.80 during the session and surpassing the previous record set …
Deutsche Bank ajuste sa position sur Ipsen ce mardi 17 février 2026.
UBS ajuste ce vendredi sa position sur le laboratoire pharmaceutique français.
Ipsen's stock has seen significant progress this Friday, surpassing the 151 euro mark in the morning, following the release of its annual 2025 results…
The biopharmaceutical group Ipsen has published its 2025 financial results, showing an increase in revenue and operating income. For the current fisca…
